A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML
Elahe Rahimian(University Hospital Carl Gustav Carus), Alexander Arthur Wurm(University Hospital Carl Gustav Carus)
Cited by 4